CAPITAL ADVISORS INC/OK – CRISPR Therapeutics AG Transaction History
CAPITAL ADVISORS INC/OK portfolio value:
$6.94M
portfolio value
CAPITAL ADVISORS INC/OK quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.97% | 2.47K shares | -709K | $65.35 | 128.36K |
| Q2 2022 | share | Increase | +19.91% | 20.90K shares | 1.06M | $60.77 | 125.88K |
| Q1 2022 | share | Increase | +2.45% | 2.51K shares | -1.17M | $62.77 | 104.98K |
| Q4 2021 | share | Increase | +45.00% | 31.8K shares | -145K | $78.85 | 102.47K |
| Q3 2021 | share | Increase | +1.71% | 1.19K shares | -3.33M | $111.93 | 70.67K |
| Q2 2021 | share | Increase | +2.54% | 1.72K shares | 2.99M | $161.89 | 69.48K |
| Q1 2021 | share | Decrease | -22.71% | -19.91K shares | -5.16M | $121.85 | 67.75K |
| Q4 2020 | share | Decrease | -35.96% | -49.23K shares | 1.97M | $153.11 | 87.66K |
| Q3 2020 | share | Increase | +0.30% | 403 shares | -1.23M | $83.64 | 136.9K |
| Q2 2020 | share | Increase | +2.18% | 2.91K shares | 7.02M | $73.49 | 136.49K |
| Q1 2020 | share | Increase | +5.16% | 6.55K shares | -2.07M | $42.41 | 133.57K |
| Q4 2019 | share | Increase | +9.36% | 10.87K shares | 2.26M | $60.91 | 127.02K |
| Q3 2019 | share | 0.00% | 0 shares | 0 | $40.99 | 116.15K | |
| Q2 2019 | share | Increase | +121.34% | 63.67K shares | 3.59M | $47.1 | 116.15K |
| Q1 2019 | share | Decrease | -55.46% | -65.34K shares | -1.49M | $35.72 | 52.47K |
| Q4 2018 | share | Increase | +9.67% | 10.38K shares | -1.39M | $28.57 | 117.81K |
| Q3 2018 | share | Increase | +0.93% | 991 shares | -1.48M | $44.35 | 107.43K |
| Q2 2018 | share | Decrease | -28.52% | -42.47K shares | -553K | $58.76 | 106.44K |
| Q1 2018 | share | Decrease | -0.53% | -787 shares | 3.29M | $45.71 | 148.91K |
| Q4 2017 | share | Increase | 0.00% | 149.70K shares | 3.51M | $23.48 | 149.70K |